Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Women taking various forms of hormonal contraceptives can likely combine them safely with antiretrovirals.
ViiV Healthcare has applied to the FDA for approval of the first two-drug antiretroviral (ARV) regimen to treat HIV.
Support grows stronger for a statement on transmission risk when undetectable.
Those who start antiretroviral (ARV) treatment for HIV soon after diagnosis experience a greater decline in bone mineral density.
A 9-year-old South African child infected with HIV at birth has been in an apparent state of extended viral remission.
Another study finds that there is no HIV transmission when viral load is fully suppressed.
Almost all of a large group of inner-city Baltimore individuals coinfected with HIV and HCV were recently cured of hep C.
People treated with VRC01 maintained undetectable viral load for up to 42 weeks after stopping antiretroviral therapy.
Continued improvements in ARVs have likely further raised life expectancy for the average 20-year-old who starts treatment today.
TaiMed Biologics has applied for approval of the weekly injectable antibody ibalizumab for people with multidrug-resistant virus.
AIDS.gov was recently rechristened to HIV.gov.
Regardless of whether individuals have hepatitis B or C, the improvement tends to occur quickly.
An edited excerpt of an opinion piece titled “Dear President Trump: A Letter From the Congressional HIV/AIDS Caucus”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.